{"id":3637,"date":"2025-10-19T12:11:52","date_gmt":"2025-10-19T16:11:52","guid":{"rendered":"https:\/\/halopharma.com\/?p=3637"},"modified":"2025-12-03T15:38:15","modified_gmt":"2025-12-03T20:38:15","slug":"john-bender-joins-woodstock-sterile-solutions-halo-pharma-as-vp-business-development","status":"publish","type":"post","link":"https:\/\/halopharma.com\/fr\/john-bender-joins-woodstock-sterile-solutions-halo-pharma-as-vp-business-development\/","title":{"rendered":"John Bender rejoint Woodstock Sterile Solutions, Halo Pharma, en tant que vice-pr\u00e9sident du d\u00e9veloppement commercial"},"content":{"rendered":"
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Woodstock, IL, August 12, 2025<\/em>\u00a0<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Bender brings 35 years of pharmaceutical industry experience to dual role<\/em><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\n

Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), and Halo Pharma, a leading CDMO specializing in pharmaceutical services, have named John Bender as the new Vice President of Business Development for the two organizations.<\/p>\n

Bender is a 35-year veteran of the pharmaceutical industry and brings deep expertise in CDMO services to his new role. He joins the organization from Alvogen Pharmaceuticals, where he most recently served as Vice President of U.S. Third Party Operations, overseeing CDMO strategic sourcing for North America. Prior to that, he was Vice President of Business Development for Alvogen\u2019s Norwich Pharma CDMO Services division.<\/p>\n

\u201cJohn\u2019s extensive experience in the CDMO sector\u2014not only in sales but also as a buyer of CDMO services\u2014along with his proven track record of building long-term partnerships comes at a great time as we look to launch sterile filling services out of Halo and grow our blow-fill-seal business as we expand our bottle packaging operations at Woodstock,\u201d said Lee Karras, Executive Chairman.<\/p>\n

John will be based in Illinois and lead sales and marketing efforts across Woodstock Sterile Solutions and Halo Pharma, focusing on expanding client partnerships and driving growth for the two CDMO businesses.<\/p>\n

\u201cSpending the last seven years \u2018on the customer side\u2019 provided me with invaluable perspective on what makes CDMOs truly exceptional\u2014from business development and customer service to operational delivery,\u201d said Bender. \u201cI look forward to bringing those insights to our team and to help shape a proactive, customer-centric business development approach that builds a strong pipeline and lasting partnerships.\u201d<\/p>\n

For more information about Woodstock Sterile Solutions, visit https:\/\/woodstocksterilesolutions.com<\/a> and for information on Halo Pharma, visit https:\/\/halopharma.com<\/a>.<\/p>\n

About Halo Pharma
<\/strong>Halo Pharma is a rapidly growing contract development and manufacturing organization (CDMO) that provides scientific and development expertise, as well as a wide spectrum of manufacturing services, from its locations in Whippany, New Jersey, USA and Montreal, Quebec, Canada to its international client base. Halo offers fully integrated capabilities in a variety of dosage forms including tablets, capsules, powders, liquids, creams, sterile and non-sterile ointments and suppositories. The company is registered to work with any of these dosages in the CI-CV DEA designations. Halo Pharma\u2019s capabilities in the areas of tech transfer, process and product development, production, scale-up\/validation and analytical method development allow us to partner with clients from development through commercialization or at any point along the way. For more information, please contact services@halopharma.com<\/a>.<\/p>\n

About Woodstock Sterile Solutions
<\/strong>For more than 55 years, Woodstock Sterile Solutions has been recognized as a leading Blow-Fill-Seal (BFS) Contract Development and Manufacturing Organization (CDMO). We develop and supply BFS products for pharmaceutical and healthcare companies, providing best-in-class sterile development manufacturing solutions across a broad \u2013 and growing \u2013 range of applications, including diagnostic, respiratory, ophthalmic, topical, otic, and oral. As a highly focused organization, our expertise and commitment to innovation allow us to reduce development times and efficiently support our customers\u2019 ability to deliver products to market. At Woodstock Sterile Solutions, we see a patient, family member or friend in every product we make, and our goal is to be the best development and commercial partner in the industry, delivering life-enhancing molecules from the benchtop to the patient.\u00a0<\/strong><\/p>\n

Media Contact
<\/strong>Resource Advantage
Dan Green
dgreen@resourceadvantage.com<\/a><\/p>\n

Company Contact
<\/strong>Woodstock Sterile Solutions
Stacy London
Stacy.london@wssterile.com<\/a><\/p>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"

Woodstock, IL, August 12, 2025\u00a0 Bender brings 35 years of pharmaceutical industry experience to dual role Woodstock Sterile Solutions, a leading blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), and Halo Pharma, a leading CDMO specializing in pharmaceutical services, have named John Bender as the new Vice President of Business Development for the two organizations. […]<\/p>\n","protected":false},"author":24,"featured_media":3638,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-3637","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3637","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=3637"}],"version-history":[{"count":12,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3637\/revisions"}],"predecessor-version":[{"id":3714,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/posts\/3637\/revisions\/3714"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/media\/3638"}],"wp:attachment":[{"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=3637"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=3637"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/halopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=3637"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}